Latest News about EXPERT ideas

Recent news which mentions EXPERT ideas

...

26 27 28 29 30 31 32 33 Next >

Beijing's Tourism Push May Boost Struggling CTG

July 30, 2025

China's Raging Retail War May Spill Into Hong Kong, As JD.com Reportedly Buys 70% Of Supermarket Chain Kai Bo

July 30, 2025

Private Markets Are Booming - But Who Really Is Partying?

July 30, 2025

Top 2 Consumer Stocks You May Want To Dump This Quarter

July 30, 2025

China Inc. - From Delhi Risks To Dairy Bust

July 30, 2025

Intuit Stock Rises 1.3% After Key Trading Signal

July 30, 2025

Top 2 Tech Stocks That May Explode In July

July 30, 2025

Top Wall Street Forecasters Revamp Etsy Expectations Ahead Of Q2 Earnings

July 30, 2025

Automatic Data Processing Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

July 30, 2025

Trump Toasts Tariff Victory As Economists Quietly Junk Their Trade Forecasts

July 29, 2025

Options Corner: Procter & Gamble's Tariff Blues Could Signal A Discounted Opportunity

July 29, 2025

Meta Q2 Preview: 11 Straight Revenue Beats On Line With Stock Near All-Time Highs

July 29, 2025

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

July 29, 2025

Behavioral Segment Concerns Overshadow Universal Health Q2 Earnings Beat

July 29, 2025

Why Tapestry Stock Is Cooling Off Despite Coach's Hot Streak

July 29, 2025

American Tower Sees Slightly Weaker US Growth As International Performance Strengthens

July 29, 2025

Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics

July 29, 2025

Why Spotify's Latest Results Look Worse Than They Are

July 29, 2025

FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers

July 29, 2025

Microsoft Q4 Preview: Can The Tech Giant Beat Forecasts For 10th Straight Quarter?

July 29, 2025

Analyst Surprised By Exelixis Q2 Revenue Miss, Delays STELLAR-304 Readout, Halts STELLAR-305 Phase 3 Plans

July 29, 2025

FDA Approval For Empaveli Marks Key Milestone In Apellis' Rare Disease Portfolio

July 29, 2025

What Prudent Investors Should Know As All-Time-Market-Highs Mix With Extreme Sentiment

July 29, 2025

Are Google's High Legal Costs A Drag on Its Stock Vs. Peers?

July 29, 2025

Tesla Valuation 'Could Far Exceed Current Levels': Analyst Sees 2 Segments Driving Most Upside (And It's Not Cars)

July 29, 2025

From Patient Capital to Active Liquidity: Rewriting the Playbook In The Post-Rate Hike Era

July 29, 2025

Incyte Surges Past Expectations With Strong Q2, Boosts Guidance On Jakafi Demand

July 29, 2025

Electronic Arts Likely To Report Lower Q1 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

July 29, 2025

Forget Bitcoin—Coinbase's Secret Weapon Fuels Growth For Free

July 29, 2025

Top 2 Tech And Telecom Stocks That Are Ticking Portfolio Bombs

July 29, 2025

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.